Nitric oxide: moving towards the clinic.
This meeting showed how the surge of research in the field of NO biology has led to novel therapeutic approaches in multiple clinical disciplines. Some approaches have already advanced towards clinical applications. Continued research efforts will undoubtedly lead to new applications.
Kilbourn
R G
RG
Section of Hematology/Oncology, Rush-Presbyterian, St. Luke's Medical Center, Chicago, IL 60612-3824, USA. rkilbour@rpslmc.edu
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology; D017321:Clinical Trials, Phase I as Topic; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D009569:Nitric Oxide / Q000378:metabolism* / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D012772:Shock, Septic / Q000188:drug therapy / Q000503:physiopathology; D019323:omega-N-Methylarginine / Q000494:pharmacology / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase